<https://european-biotechnology.com/latest-news/fda-approves-pan-tumour-genomic-profiling-assay/>
<http://schema.org/description>
"Roche company Foundation Medicine Inc. (FMI) has been granted FDA approval for a diagnostic multiplex tumour profiling assay, which identifies a broad range of tumour markers in one single measurement."
<https://european-biotechnology.com/latest-news/fda-approves-pan-tumour-genomic-profiling-assay/>